Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Ann Surg. 2018 May;267(5):898–904. doi: 10.1097/SLA.0000000000002306

Table 4.

Multivariate Analyses

HR [95% CI] p-value

Model Parameter Level
GE Junction LVI No REF
Baseline Pathologic Model Yes 2.78 [1.57 – 4.93] 0.0005
N Stage N0 REF
N1+ 2.71 [1.49 – 4.92] 0.0010

Gastric T Stage T0–T1b REF
Baseline Pathologic Model T2 0.40 [0.04 – 4.51] 0.0217
T3–T4 3.87 [0.89 – 16.89]
N Stage N0 REF
N1+ 7.09 [2.08 – 24.22] 0.0018

GE Junction SUVmax Response 1.00 [1.00 – 1.01] 0.20
Pathologic Model + SUVmax Response LVI No REF
Yes 2.97 [1.66 – 5.30] 0.0002
N Stage N0 REF
N1+ 2.27 [1.50 – 4.92] 0.0010

Gastric SUVmax Response 1.00 [0.99 – 1.01] 0.66
Pathologic Model + SUVmax Response T Stage T0–T1b REF
T2 0.40 [0.04 – 4.51] 0.0253
T3–T4 3.87 [0.89 – 16.89]
N Stage N0 REF
N1+ 7.05 [2.06 – 24.10] 0.0019